Skip to main content

Table 2 Baseline characteristics at admission of patients who required ICU care or died and those who did not

From: Covid-19 in South America: clinical and epidemiological characteristics among 381 patients during the early phase of the pandemic in Santiago, Chile

 

All hospitalized N = 88

ICU care or death N = 18

Non-ICU care N = 70

p-value

Demographics

 Age, years

49 (39.5–65)

68.5 (59–72)

46 (38–58)

.000

 Gender, female

45 (51.1)

3 (16.7)

42 (60)

.003

Symptoms on admission

 Cough

64 (72.7)

13 (72.2)

51 (72.9)

.96

 Fever

69 (78.4)

15 (83.3)

54 (77.1)

.64

 Anosmia

7 (8)

0

7 (10)

.16

 Ageusia

3 (3.4)

0

3 (4.3)

.37

 Odynophagia

35 (39.8)

7 (38.9)

28 (40)

.93

 Fatigue

38 (43.2)

6 (33.3)

32 (45.7)

.35

 Dyspnea

4 (4.5)

2 (11.1)

2 (2.9)

.16

 Chest pain

5 (5.7)

0

5 (7.1)

.24

Comorbidities

 Diabetes

6 (6.8)

3 (16.7)

3 (4.3)

.06

 Hypertension

25 (28.4)

10 (55.6)

15 (21.4)

.004

 Mean BMI (SD)

26.5 (3.8)

29.2 (3.9)

25.7 (3.5)

.002

 Smoker

6 (6.8)

1 (5.6)

5 (7.1)

.81

 COPD or Asthma

6 (6.8)

3 (16.7)

3 (4.3)

0.097

 Mean CCS (SD)

1.38(1.96)

3(2.3)

0.96 (1.62)

.001

Physical exam

 Heart rate

81 (74–89)

86 (75–97)

80.5(74–88)

.23

 T > 37.5 C (axillary)

42/48 (87.5)

8/9 (88.9)

34/39 (87.2)

0.89

 Respiratory rate

20 (18–22)

21(20–24)

20(18–22)

.13

 SBP < 90 Or MAP < 65 mmHg

9/81 (11.1)

1/13 (7.7)

8/68 (11.8)

1.0

S SpO2/FiO2

452.4 (404.2–461.9)

317.9 (248.6–447.6)

457.14 (447.6–466.7)

<.0001

Chronic Medications

 ARBs/ACEi

18/87 (20.7)

9/17 (52.9)

9/70 (12.9)

<.001

 Steroids

4 (4.5)

4 (22.2)

0

.001